Standardizing dysgranulopoiesis in MDS and AML: refining diagnostics and laying the foundation for novel morphological-genetic correlations.
Rauh MJ.
Leuk Res. 2014 Apr;38(4):428-9. doi: 10.1016/j.leukres.2014.01.003. Epub 2014 Jan 11.
PMID:24472687
Atypical chronic myeloid leukemia and myelodysplastic/myeloproliferative neoplasm, not otherwise specified: 2023 update on diagnosis, risk stratification, and management.
Patnaik MM, Tefferi A.
Am J Hematol. 2023 Apr;98(4):681-689. doi: 10.1002/ajh.26828. Epub 2023 Jan 4.
PMID:36601682
Images from the Haematologica Atlas of Hematologic Cytology: dysgranulopoiesis.
Invernizzi R.
Haematologica. 2021 May 1;106(5):1229. doi: 10.3324/haematol.2021.278517.
PMID:33938210
Proposal for refining the definition of dysgranulopoiesis in acute myeloid leukemia and myelodysplastic syndromes.
Goasguen JE, Bennett JM, Bain BJ, Brunning R, Vallespi MT, Tomonaga M, Zini G, Renault A; International Working Group on Morphology of MDS (IWGM-MDS).
Leuk Res. 2014 Apr;38(4):447-53. doi: 10.1016/j.leukres.2013.12.020. Epub 2013 Dec 29.
PMID:24439566
Abnormal neutrophil scattergram obtained using Pentra MS CRP in the patients with myelodysplastic syndrome showing dysgranulopoiesis.
Inaba T, Ishizuka K, Yuasa S, Mishima N, Ogura K, Saito K, Kohno T, Fujitomo Y, Nakanishi M, Fujita N.